Satsuma Pharmaceuticals, Inc.

STSA · NASDAQ
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Assets
Cash & Equivalents$19,526$16,429$40,556$23,763
Short-Term Investments$21,844$36,052$23,880$44,300
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,005$2,328$3,127$4,411
Total Curr. Assets$43,375$54,809$67,563$72,474
Property Plant & Equip (Net)$82$108$6,923$7,112
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$22$22$551$565
Total NC Assets$104$130$7,474$7,677
Other Assets$0$0$0$0
Total Assets$43,479$54,939$75,037$80,151
Liabilities
Payables$874$1,911$1,940$1,627
Short-Term Debt$116$138$172$135
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$4,841$6,066$4,546$6,130
Total Curr. Liab.$5,831$8,115$6,658$7,892
LT Debt$0$0$0$70
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$990$2,049$2,112$70
Other Liabilities-$990-$2,049-$2,112$0
Cap. Leases$0$0$0$0
Total Liabilities$5,831$8,115$6,658$7,962
Equity
Pref Stock$0$0$0$0
Common Stock$3$3$3$3
Retained Earnings-$222,085-$211,791-$188,661-$173,521
AOCI-$5-$30-$63-$107
Other Equity$259,735$27$257,100$245,814
Total Equity$37,648-$211,791$68,379$72,189
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$43,479$54,939$75,037$80,151
Net Debt-$19,410-$16,291-$40,384-$23,558
Satsuma Pharmaceuticals, Inc. (STSA) Financial Statements & Key Stats | AlphaPilot